Healthcare
Weight-Loss Drug Cuts Bipolar Hospitalization Risk
A study by Griffith University found that the weight-loss drug semaglutide reduced psychiatric hospitalizations in bipolar patients by 21 percent.
A study by Griffith University found that the weight-loss drug semaglutide reduced psychiatric hospitalizations in bipolar patients by 21 percent.